Permanent Pacemaker and Implantable Cardioverter Defibrillator Infections Seven Years of Diagnostic and Therapeutic Experience of a Single Center
 
Yazarlar (12)
Mustafa Cengiz Hacettepe Üniversitesi, Türkiye
Prof. Dr. Sercan Okutucu Hacettepe Üniversitesi, Türkiye
Sibel Ascioglu Hacettepe Üniversitesi, Türkiye
Prof. Dr. Abdurahman ŞAHİN Hacettepe Üniversitesi, Türkiye
Prof. Dr. Hakan Aksoy Hacettepe Üniversitesi, Türkiye
Prof. Dr. Onur Sinan Deveci Hacettepe Üniversitesi, Türkiye
Prof. Dr. Ergun Baris Kaya Hacettepe Üniversitesi, Türkiye
Prof. Dr. Kudret Aytemir Hacettepe Üniversitesi, Türkiye
Giray Kabakci
Hacettepe Üniversitesi, Türkiye
Lale Tokgozoglu
Hacettepe Üniversitesi, Türkiye
Hilmi Ozkutlu
Hacettepe Üniversitesi, Türkiye
Ali Oto
Hacettepe Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Clinical Cardiology
Dergi ISSN 0160-9289 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 07-2010
Cilt / Sayı / Sayfa 33 / 7 / 406–411 DOI 10.1002/clc.20765
Makale Linki http://doi.wiley.com/10.1002/clc.20765
UAK Araştırma Alanları
Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji
Özet
Background Increasing evidence‐based indications for the implantation of permanent pacemakers (PMs) and implantable cardioverter defibrillators (ICDs) have led to an increase in the rate of device infections. The aim of the present study was to evaluate infection frequency, clinical characteristics, risk factors, and microbiologic and therapeutic features in patients with PM/ICD infections. Hypothesis Clinical and demographic characteristics of the patients can affect the PM/ICD infections. Methods The PM/ICD infection group consisted of 57 patients diagnosed and treated with PM/ICD infections in our hospital. The control group in this case‐control study consisted of 833 patients in whom a PM or ICD had been implanted and no infections were noted. Results Patients with PM/ICD infections (median age 65 years; range, 18–104 years) were older than those without PM/ICD infections (median age 58 years …
Anahtar Kelimeler